109 related articles for article (PubMed ID: 38728425)
1. Transferrin Immobilized Graphene Oxide Nanocomposite for Targeted Cancer Chemodynamic Therapy via Increasing Intracellular Labile Fe
Shukla AK; Verma M; Bathla M; Randhawa S; Saini TC; Kumari A; Acharya A
ACS Appl Bio Mater; 2024 Jun; 7(6):3649-3659. PubMed ID: 38728425
[TBL] [Abstract][Full Text] [Related]
2. Quercetin-mediated synthesis of graphene oxide-silver nanoparticle nanocomposites: a suitable alternative nanotherapy for neuroblastoma.
Yuan YG; Wang YH; Xing HH; Gurunathan S
Int J Nanomedicine; 2017; 12():5819-5839. PubMed ID: 28860751
[TBL] [Abstract][Full Text] [Related]
3. Unprecedented Approach of Fabrication and Analysis of a Bioactive PDMS/Hydroxyapatite/Graphene Nanocomposite Scaffold with a Vascular Channel to Combat Carcinogenesis.
Ayyanar C; Rakshit S; Sarkar K; Pramanik S
ACS Appl Bio Mater; 2024 May; 7(5):3388-3402. PubMed ID: 38660938
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of Nucleotide-Stabilized Graphene Dispersions on Osteosarcoma and Healthy Cells: On the Way to Safe Theranostics Agents.
Cicuéndez M; Coimbra A; Santos J; Oliveira H; Ayán Varela M; Paredes JI; Villar Rodil S; Vila M; Silva VS
ACS Appl Bio Mater; 2021 May; 4(5):4384-4393. PubMed ID: 35006850
[TBL] [Abstract][Full Text] [Related]
5. CdSe- Reduced graphene oxide nanocomposite toxicity alleviation via V
Singh AK; Yadav AN; Srivastav S; Jaiswal RK; Srivastava A; Mondal AC; Singh K
Nanotechnology; 2020 Oct; 31(41):415101. PubMed ID: 32311687
[TBL] [Abstract][Full Text] [Related]
6. PEGAylated graphene oxide/superparamagnetic nanocomposite as a high-efficiency loading nanocarrier for controlled delivery of methotrexate.
Abdollahi Z; Taheri-Kafrani A; Bahrani SA; Kajani AA
J Biotechnol; 2019 Jun; 298():88-97. PubMed ID: 30986517
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation of drug-resistant cancer cells using molecularly targeted carboxyl-functionalized biodegradable graphene.
Sasidharan A; Sivaram AJ; Retnakumari AP; Chandran P; Malarvizhi GL; Nair S; Koyakutty M
Adv Healthc Mater; 2015 Apr; 4(5):679-84. PubMed ID: 25586821
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible ι-carrageenan-γ-maghemite nanocomposite for biomedical applications - synthesis, characterization and in vitro anticancer efficacy.
Raman M; Devi V; Doble M
J Nanobiotechnology; 2015 Mar; 13():18. PubMed ID: 25890231
[TBL] [Abstract][Full Text] [Related]
9. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
10. MOF-derived cobalt-iron containing nanocomposite with cascade-catalytic activities for multimodal synergistic tumor therapy.
Jiang Y; Lu H; Lei L; Yuan X; Scherman D; Liu Y
Colloids Surf B Biointerfaces; 2024 Aug; 240():113981. PubMed ID: 38815310
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and investigation of synergistic antibacterial activity and cell viability of silver-sulfur doped graphene quantum dot (Ag@S-GQDs) nanocomposites.
Kadian S; Manik G; Das N; Nehra P; Chauhan RP; Roy P
J Mater Chem B; 2020 Apr; 8(15):3028-3037. PubMed ID: 32186305
[TBL] [Abstract][Full Text] [Related]
12. Anti-Angiogenic and Anti-Proliferative Graphene Oxide Nanosheets for Tumor Cell Therapy.
Verde V; Longo A; Cucci LM; Sanfilippo V; Magrì A; Satriano C; Anfuso CD; Lupo G; La Mendola D
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759830
[TBL] [Abstract][Full Text] [Related]
13. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.
Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283
[TBL] [Abstract][Full Text] [Related]
14. Graphene oxide-methylene blue nanocomposite in photodynamic therapy of human breast cancer.
Hosseinzadeh R; Khorsandi K; Hosseinzadeh G
J Biomol Struct Dyn; 2018 Jul; 36(9):2216-2223. PubMed ID: 28681663
[TBL] [Abstract][Full Text] [Related]
15. Development of a nanocomposite scaffold of gelatin-alginate-graphene oxide for bone tissue engineering.
Purohit SD; Bhaskar R; Singh H; Yadav I; Gupta MK; Mishra NC
Int J Biol Macromol; 2019 Jul; 133():592-602. PubMed ID: 31004650
[TBL] [Abstract][Full Text] [Related]
16. CuPc-Fe@BSA nanocomposite: Intracellular acid-sensitive aggregation for enhanced sonodynamic and chemo-therapy.
Bai Q; Wang M; Wang K; Liu J; Qu F; Lin H
J Colloid Interface Sci; 2024 Oct; 671():577-588. PubMed ID: 38820842
[TBL] [Abstract][Full Text] [Related]
17. Traceable Nanocluster-Prodrug Conjugate for Chemo-photodynamic Combinatorial Therapy of Non-small Cell Lung Cancer.
Srinivasulu YG; Mozhi A; Goswami N; Yao Q; Xie J
ACS Appl Bio Mater; 2021 Apr; 4(4):3232-3245. PubMed ID: 35014410
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Molecular Effects of a Reduced Graphene Oxide/Fe
Barrera CC; Groot H; Vargas WL; Narváez DM
Int J Nanomedicine; 2020; 15():6421-6432. PubMed ID: 32922009
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Theranostic Graphene Oxide Nanoflakes as MR Imaging Agents with Enhanced Photothermal and Radiosensitizing Properties.
Beik J; Alamzadeh Z; Mirrahimi M; Sarikhani A; Ardakani TS; Asadi M; Irajirad R; Mirrahimi M; Mahabadi VP; Eslahi N; Bulte JWM; Ghaznavi H; Shakeri-Zadeh A
ACS Appl Bio Mater; 2021 May; 4(5):4280-4291. PubMed ID: 35006840
[TBL] [Abstract][Full Text] [Related]
20. Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene.
Gurunathan S; Han JW; Park JH; Eppakayala V; Kim JH
Int J Nanomedicine; 2014; 9():363-77. PubMed ID: 24453487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
